The effect of auricular acupressure on pruritus, xerostomia, and fatigue of patients undergoing hemodialysis in Kerman University of Medical Sciences

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151107024919N14

Enrollment

Registered

2022-12-12

Start date

2022-11-22

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: pruritus. Condition 2: xerostomia. Condition 3: fatigue. Other pruritus Disturbances of salivary secretion Malaise and fatigue

Interventions

Intervention 1: Intervention group: The intervention includes ear acupressure using Vacaria plant seeds in the specified points on the ear for the intervention group. The intervention lasts 4 weeks

According to the hemodialysis program, adhesives and beads will be replaced with new adhesives and beads every 2 to 3 days. Intervention 2: Control group: For people in the control group, adhesives wi

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patient age between 18_75 years Regular hemodialysis Having at least 3 scores on the VAS visual analog scale for pruritus and experiencing xerostomia and fatigue in the last month

Exclusion criteria

Exclusion criteria: Existence of concomitant diseases including: cancer, congestive heart failure, connective tissue disease, hematological diseases and liver diseases. The presence of severe physical symptoms that clearly cause insomnia and fatigue, such as bone pain, sleep apnea, and restless legs. Fatigue due to severe anemia (hemoglobin <60 g/L) or malnutrition (serum albumin <30 g/L) ear infection Allergy to Vaccaria seeds Use of medications that may cause xerostomia (such as anticholinergics, tricyclic antidepressants, and beta blockers) Use of drugs that may cause pruritus (such as drugs and substances to which the patient is allergic, narcotic painkillers, antifungals).

Design outcomes

Primary

Measure	Time frame
Pruritus. Timepoint: pruritus is measured before the intervention and at the end of the intervention. Method of measurement: Visual analog scale.;Xerostomia. Timepoint: xerostomia is measured before the intervention and at the end of the intervention. Method of measurement: Summated Xerostomia Inventory.;Fatigue. Timepoint: fatigue is measured before the intervention and at the end of the intervention. Method of measurement: Fatigue Severity Scale.	—

Measure

Time frame

Pruritus. Timepoint: pruritus is measured before the intervention and at the end of the intervention. Method of measurement: Visual analog scale.;Xerostomia. Timepoint: xerostomia is measured before the intervention and at the end of the intervention. Method of measurement: Summated Xerostomia Inventory.;Fatigue. Timepoint: fatigue is measured before the intervention and at the end of the intervention. Method of measurement: Fatigue Severity Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBatoul Tirgari

Kerman University of Medical Sciences

B_tirgari@kmu.ac.ir+98 34 3132 5207

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026